1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Registration for the Commissioner’s National Priority Voucher (CNPV) Pilot Program Public Hearing
  1. FDA Meetings, Conferences and Workshops

Registration for the Commissioner’s National Priority Voucher (CNPV) Pilot Program Public Hearing

Please note that the date for our upcoming Commissioner’s National Priority Voucher (CNPV) Pilot Program Public Hearing has been changed to June 4, 2026.

The Food and Drug Administration (FDA) is hosting a hybrid public hearing to gather feedback on the Commissioner’s National Priority Voucher (CNPV) Pilot Program. This program aims to expedite review times for drug and biological products aligned with national health priorities.

All requests for participation, including for those who wish to present during the public hearing, must be received by 11:59 p.m. ET, April 24, 2026, through the meeting registration page.  

Questions about meeting registration and participation should be sent to CNPVPublicMeeting@fda.hhs.gov and include the title of this notice: “Commissioner's National Priority Voucher (CNPV) Pilot Program; Public Hearing; Request for Comments”.

Event Details

  • Date: June 4, 2026
  • Time: 1:00 p.m. – 4:00 p.m. ET
  • Format: Hybrid (In-person and Virtual)
  • In-Person Location:
    FDA’s White Oak Campus, Building 31, Room 1503 - Great Room
    10903 New Hampshire Avenue, Silver Spring, Maryland 20993

    FDA Campus Information (e.g., local airports, directions, and local hotels)

Registration Instructions

To attend and/or request to present in this hearing, please complete the registration process by the deadline noted below. If you wish to provide an oral statement during the hearing, you must indicate this during registration.

  • Deadline for Presenter Requests: April 24, 2026, by 11:59 p.m. ET.
  • Requirements: Presentations are limited to oral statements only (no slides). Commercial or promotional materials are prohibited.
  • Special Accommodations: If you require special accommodations due to a disability, please submit your request through the registration form. Live closed captioning will be provided for all virtual attendees.

Note: Due to time constraints, the FDA may request that individuals with common interests consolidate their remarks. You will be notified of your allotted time slot prior to the hearing.
 

More information: Federal Register Notice

 
Back to Top